Targeted therapy aimed at cancer stem cells: Wilms’ tumor as an example

A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia

(2012) J. M. Gerber et al.   BLOOD

The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

(2012) Naomi Pode-Shakked et al.   EMBO Molecular Medicine

Wilms tumor—a renal stem cell malignancy?

(2011) Naomi Pode-Shakked et al.   PEDIATRIC NEPHROLOGY

Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells

(2010) Christoph Stein et al.   BRITISH JOURNAL OF HAEMATOLOGY

Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network

(2010) Aviva Presser Aiden et al.   Cell Stem Cell

Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors

(2010) Irma W.E.M. van Dijk et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

(2010) Malcolm A. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer stem cells: problems for therapy?

(2010) Malcolm R Alison et al.   JOURNAL OF PATHOLOGY

Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?

(2010) Mahendra P. Deonarain et al.   mAbs

Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells

(2010) D. Evseenko et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer

(2009) Yu-Chih Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells

(2009) Liqing Jin et al.   Cell Stem Cell

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

LATE EFFECTS OF TREATMENT FOR WILMS TUMOR

(2009) Karen D. Wright et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Expression of Stem Cell Markers in the Human Fetal Kidney

(2009) Sally Metsuyanim et al.   PLoS One

Breast cancer chemoresistance: Emerging importance of cancer stem cells

(2009) Suebwong Chuthapisith et al.   SURGICAL ONCOLOGY-OXFORD

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

(2008) L M Smith et al.   BRITISH JOURNAL OF CANCER

Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA

(2008) E. Sagiv et al.   CANCER RESEARCH

Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population

(2008) Naomi Pode-Shakked et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations

(2008) S. Ma et al.   MOLECULAR CANCER RESEARCH

Rational targeting of Notch signaling in cancer

(2008) P Rizzo et al.   ONCOGENE

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

(2008) Scott J. Dylla et al.   PLoS One

Accumulation of Malignant Renal Stem Cells Is Associated with Epigenetic Changes in Normal Renal Progenitor Genes

(2008) Sally Metsuyanim et al.   STEM CELLS